1. Home
  2. WINT vs LYT Comparison

WINT vs LYT Comparison

Compare WINT & LYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WINT
  • LYT
  • Stock Information
  • Founded
  • WINT 1992
  • LYT 2020
  • Country
  • WINT United States
  • LYT India
  • Employees
  • WINT N/A
  • LYT N/A
  • Industry
  • WINT Biotechnology: Biological Products (No Diagnostic Substances)
  • LYT EDP Services
  • Sector
  • WINT Health Care
  • LYT Technology
  • Exchange
  • WINT Nasdaq
  • LYT Nasdaq
  • Market Cap
  • WINT 2.0M
  • LYT 1.8M
  • IPO Year
  • WINT 1995
  • LYT 2022
  • Fundamental
  • Price
  • WINT $0.12
  • LYT $0.43
  • Analyst Decision
  • WINT Hold
  • LYT
  • Analyst Count
  • WINT 1
  • LYT 0
  • Target Price
  • WINT $7.00
  • LYT N/A
  • AVG Volume (30 Days)
  • WINT 7.3M
  • LYT 484.5K
  • Earning Date
  • WINT 11-27-2024
  • LYT 08-15-2024
  • Dividend Yield
  • WINT N/A
  • LYT N/A
  • EPS Growth
  • WINT N/A
  • LYT N/A
  • EPS
  • WINT N/A
  • LYT 0.30
  • Revenue
  • WINT N/A
  • LYT $21,363,775.00
  • Revenue This Year
  • WINT N/A
  • LYT N/A
  • Revenue Next Year
  • WINT N/A
  • LYT N/A
  • P/E Ratio
  • WINT N/A
  • LYT $2.02
  • Revenue Growth
  • WINT N/A
  • LYT 12.39
  • 52 Week Low
  • WINT $0.11
  • LYT $0.54
  • 52 Week High
  • WINT $14.75
  • LYT $18.62
  • Technical
  • Relative Strength Index (RSI)
  • WINT 15.60
  • LYT 17.47
  • Support Level
  • WINT $0.21
  • LYT $0.63
  • Resistance Level
  • WINT $0.33
  • LYT $0.68
  • Average True Range (ATR)
  • WINT 0.03
  • LYT 0.07
  • MACD
  • WINT 0.00
  • LYT 0.00
  • Stochastic Oscillator
  • WINT 2.15
  • LYT 6.49

About WINT Windtree Therapeutics Inc.

Windtree Therapeutics Inc is a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases. Its portfolio of product candidates includes istaroxime, a Phase 2 candidate with sarco endoplasmic reticulum Ca2+ -ATPase 2a, or SERCA2a, activating properties for acute heart failure and associated cardiogenic shock, preclinical SERCA2a activators for heart failure, rostafuroxin for the treatment of hypertension in patients with a specific genetic profile, and a preclinical atypical protein kinase C iota, or aPKCi, inhibitor, being developed for potential application in rare and broad oncology indications. It operates in one operating segment, which is the research and development of products focused on cardiovascular disease.

About LYT Lytus Technologies Holdings PTV. Ltd.

Lytus Technologies Holdings Pvt Ltd is a platform services company providing content streaming/telecasting services to users located all across India. Its scope of business also covers telemedicine services with local assistance through local Health Centers. Through its platform, the customers are well connected via customer premises equipment (CPE) devices/set-top boxes (STBs) and have access to multi-dimensional services including telemedicine service.

Share on Social Networks: